3-(5-methyl-1,2,4-oxadiazol-3-yl)piperidine hydrochloride, 95.0%, 1g

2-(1-(((9H-Fluoren-9-yl)methoxy)carbonyl)piperidin-3-yl)acetic acid, 97%, 5g

2-acetamido-3-methyl-3-(nitrososulfanyl)butanoic acid, 95.0%, 1g

2-Ethyl-2-hexenal, 95.0%, 5g

4-Chlorobenzylsulfonamide, 97.0%, 5g

4-Amino-3-iodobenzoic acid, 97.0%, 5g

4-(2-Methyl-2H-tetrazol-5-yl)-benzenesulfonamide, 95.0%, 1g

TERT-BUTYL (E)-(3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)ALLYL)CARBAMATE, 95.0%, 1g

3-Methyl-4-nitrophenol, 99.0%, 25g

tert-butyl méthyl éther, min 99,5 %, pour la synthèse, 10 l, blister blanc

CIS-4,7,10,13,16,19-DOCOSAHEXAENOIC ACID ETHYL ESTER, 95%, 1g

2-(2-(1-Chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl)-1H-1,2,4-triazole-3(2H)-thione, 95.0%, 1g

H-Ala-Trp-OH>98.0%(HPLC)(T)250mg